Drs. Abdel-Rahman and Lewis Named to ASCPT Leadership Positions
The American Society for Clinical Pharmacology and Therapeutics (ASCPT) has selected two Children's Mercy faculty to serve in key leadership positions.
Dr. Abdel-Rahman chosen as ASCPT President-Elect
Susan Abdel-Rahman, PharmD, Professor, Section Chief, and Director of Innovation in Health Care Delivery for the Children's Research Institute, has been selected as the incoming President-Elect for the American Society of Clinical Pharmacology and Therapeutics. As a member, Dr. Rahman has served on the Education Committee, Scientific Awards Committee, Board of Directors, and most recently as Chair of the Scientific Program committee. She has been responsible for developing several junior and mid-career initiatives, including mentoring and leadership programs. In March, Dr. Rahman will become a member of the ASCPT Executive Committee and an ex efficio member of other Board-designated committees and she will take the reins as President of the Society at the Annual Meeting in 2020.
Dr. Lewis appointed to ASCPT Board of Directors
Tamorah Lewis, MD, PhD, Assistant Professor, Divisions of Neonatology and Clinical Pharmacology, Toxicology, and Therapeutic Innovation, was recently selected to serve as a Director At-Large on the Board of Directors for ASCPT. Dr. Lewis is one of three new board members slated to start their term in March of 2019. Dr. Lewis has been a member of ASCPT since 2011 and has served as a member of the Scientific Program Committee. In addition to her ASCPT service, Dr. Lewis sits on the Executive Committee for the AAP Section of Clinical Pharmacology and Therapeutics and is an ad hoc member of the FDA's Pediatric Advisory Committee.
Founded in 1900, the ASCPT is one of the oldest and largest scientific and professional organizations serving the disciplines of clinical pharmacology and translational medicine.
Children’s Mercy Kansas City is ranked as one of “America's Best Children's Hospitals” in nine specialties rated by U.S. News & World Report and has received MagnetTM recognition for excellence in nursing services five consecutive times. With 386 licensed beds and a medical staff of more than 750 pediatric subspecialists, we care for children from all 50 states and from around the world. In addition, our leadership in pediatric genomic medicine and individualized pediatric therapeutics is driving research and innovation in neonatology, nephrology, endocrinology, gastroenterology, neurology, heart, cancer and other subspecialties to transform outcomes for children. Children’s Mercy also is nationally recognized for innovation in psychosocial care and creating a family-centered environment focused on the unique needs of hospitalized children and their families. Our love for children powers everything we do, inspiring our research, innovations and our everyday care. Because love has no limits. And with it, neither do we.